Specialty Pharmacy & Distribution

Specialty Drugs Fill 2017 Pipeline
- May 04, 2017
New therapies to treat inflammatory conditions, multiple sclerosis, and cancer are among the products highlighted in Express Scripts’ Specialty Pipeline report. In 2016, specialty drugs made up 71% of the 24 drugs approved by the FDA...
UBC leverages prescription data to provide drug launch insights
Klaira Simon, Associate Director, New Solutions - April 25, 2017
As an Express Scripts company, UBC offers pharmaceutical and biotech manufacturers the chance to monitor their newly launched drugs using a proprietary, HIPAA-compliant tool to generate real-time reports. As a primary data source with...
Tagged in:
NORD 2016 takeaways
UBC - October 27, 2016
Members from both UBC and Accredo recently attended NORD’s Rare Diseases and Orphan Products Breakthrough Summit in Arlington, VA. This was a great opportunity for leaders from both organizations to collaborate with key industry...
Market access for specialty drugs
UBC - October 17, 2016
According to Express Scripts 2015 Drug Trend Report, despite being used by only 1-2% of the population, specialty medications accounted for 37% of U.S. drug spend in 2015 and are projected to reach 50% by 2018. As the specialty market...
Cancer Care Solutions | UBC
- June 01, 2016
At age twelve, I watched my grandmother lose her three year battle with lung cancer. Her battle and my family’s support showed me that while cancer is personal, it takes a village to fight it. That tragic event put me on a course of...